ARCHIVES

Hammer Agrees To Bush Request for FDA Probe

This article is from The Cancer Letter archive.

Vol. 14 No. 29 | July 15, 1988

Download PDF Visit The Full Archive

Related Articles

New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com.

August 8, 2003

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

NCI To Place 20% Cap On Grant Renewal Increases.

May 25, 2001

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007